We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Drug Target for Ewing Sarcoma Identified

News   Jan 29, 2018 | Original story from Boston Children's Hospital

 
Drug Target for Ewing Sarcoma Identified

Infographic showing how PARP and CDK12 inhibition lead to deficient DNA damage repair and cell death in Ewing sarcoma cells. Credit: Dana-Farber/Boston Children's Cancer and Blood Disorders Center

 
 
Advertisement
 

RELATED ARTICLES

FDA Approves a Novel Medicine Invented at Scripps Research, For Treatment of Multiple Sclerosis

News

Ozanimod is the latest in a series of novel medicines to originate from the laboratories of Scripps Research.

READ MORE

The National Gene Vector Biorepository

News

Gene therapy investigators can greatly benefit from the resources and services provided by the National Gene Vector Biorepository.

READ MORE

Aiding COVID-19 Data Analysis

News

Researchers from the Centre for Genomic Regulation (CRG) have launched a new database to advance the international research efforts studying COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE